2nd ALS Drug Development Summit Hilton Boston Logan Airport, Boston

Following the approval of Amylyx’s Relyvrio in the US and Canada and further FDA decisions on the horizon in 2023, the ALS drug development landscape is gaining momentum and positivity. With booming pharma investment and new biotechs entering the field, there are still crucial translational challenges to address to bridge the gap and see clinical success for the wider ALS patient population.

Returning to Boston, the timely 2nd Annual ALS Drug Development Summit is the only industry-focused conference dedicated to overcoming preclinical and clinical challenges currently facing ALS pipelines. This is your must-attend meeting showcasing the latest breakthroughs in ALS in 2022 and 2023.

⌛ Event Dates & Venue

16 May - 18 May 2023, 9:00 am - 4:30 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Drug Developer - Conference + 2 Workshops: USD 3597.00, Drug Developer - Conference + 1 Workshop: USD 3098.00, Drug Developer - Conference Only: USD 2599.00, Solution Provider - Conference + 2 Workshops: USD 5297.00, Solution Provider - Conference + 1 Workshop: USD 4548.00, Solution Provider - Conference Only: USD 3799.00

◑ Topics | Categories